Role of amiodarone in the management of atrial arrhythmias in adult Fontan patients.
Satoshi KawadaPraloy ChakrabortyLucy RocheErwin N OechslinCandice SilversidesRachel M WaldEugene DownarLouise HarrisLorna SwanRafael Alonso-GonzalezSara ThorneKenichiro YamamuraKumaraswamy NanthakumarBlandine MondésertPaul KhairyKrishnakumar NairPublished in: Heart (British Cardiac Society) (2020)
Short-term efficacy of amiodarone in Fontan physiology is acceptable. However, long-term administration is associated with a reduction of efficacy and a significant prevalence of non-cardiac side effects. AIT is associated with exacerbation of HF. The judicious use of amiodarone administration should be considered in this population.